The
FDA have an interesting poster, as part of their advancing regulatory science
series, titled ‘Characterization of intracellular ATP Iuminescence assay for
rapid evaluation of tuberculosis vaccine (Mycobacterium
bovis BCG)’.
The
FDA explains that “The current assay used to evaluate the potency of
Mycobacterium bovis BCG vaccine is time-consuming, labor-intensive, and often
yields irreproducible results. An assay that measures ATP levels in M. bovis through bioluminescence might
solve those problems.”
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources